|
| Wednesday, July 24, 2019 |
|
|
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit |
| SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce the results of clinical trials conducted on Laetose(TM), developed by its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"). more info >> |
|
| Monday, January 28, 2019 |
|
|
Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis |
| SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial Fragrance, which shows efficacy against tuberculosis. more info >> |
|
| Wednesday, January 16, 2019 |
|
|
Two Malaysian Companies to Develop Breakthrough Low GI Roti Canai |
| Food ingredient specialist Holista CollTech Ltd (ASX:HCT, "Holista") has partnered Bursa Malaysia-listed Kawan Food Berhad ("Kawan Food") to produce healthy Asian flatbreads, including roti canai, roti and chappati, for local and international markets. more info >> |
|
| Thursday, February 15, 2018 |
|
|
Holista signs US$6M MOU to supply Low-GI Noodle Mix to Wing's of Canada |
| Holista CollTech Ltd (Holista; ASX: HCT) is pleased to announce that group company Holista Foods Inc. (Holista Foods) has signed a 3-year MoU to supply its patented low glycemic index (GI) mix to Ontario-based Wing's, North America's leading noodle supplier. more info >> |
|
| Wednesday, February 14, 2018 |
|
|
Holista Group Company signs US$6M MOU to supply Low-GI Noodle Mix to Wing's of Canada |
| Holista CollTech Ltd ("Holista") (ASX: HCT) is pleased to announce group company Holista Food's Inc. ("HolistaFoods") has signed a 3-year MoU to supply its patented low glycemic index ("GI") mix to Wing's Group - North America's leading noodle supplier. more info >> |
|
| Tuesday, October 24, 2017 |
|
|
Singapore eDevelopment's Global BioLife develops Low-GI Modified Sugar |
| SGX-listed Singapore eDevelopment Ltd ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has developed a breakthrough low-calorie, low glycemic index, natural, modified sugar Laetose -- which has the potential to affect the world's sugar market. more info >> |
|
| Thursday, October 19, 2017 |
|
|
ASX-Listed Holista and Holista Foods Inc. (USA) Develop Breakthrough Noodle Formula with Low-Glycemic Score of 38 |
| Australian Securities Exchange-listed food ingredient specialist Holista CollTech Ltd (ASX: HCT, "Holista") announced today that it has developed a breakthrough noodle formula certified to have a low Glycemic Index ("GI") - opening a major market for a healthier version of the staple which is vital in the global fight against diabetes and obesity. more info >> |
|
| Tuesday, August 15, 2017 |
|
|
Singapore eDevelopment's Global BioLife and Chemia Corp. to develop 3F suite of Functional Fragrances |
| Singapore eDevelopment Ltd (SeD; SGX:SGE) has announced that its indirect subsidiary, Global BioLife Inc., is collaborating with U.S.-based Chemia Corporation to develop specialised fragrances which can counter mosquito-borne diseases, diminish stress and anxiety, and act in anti-viral medical applications. more info >> |
|
| Monday, May 22, 2017 |
|
|
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform |
| Singapore eDevelopment Limited ("SeD") subsidiary Global BioLife Inc. has initiated advanced research of a new universal therapeutic drug platform, known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer. more info >> |
|
|
|
|
